Eli Lilly & Co. (LLY)
1247.64
-7.76
(-0.62%)
USD |
NYSE |
Aug 24, 16:00
1249.23
+1.60
(+0.13%)
After-Hours: 20:00
Eli Lilly Total Assets (Quarterly) : 142.28B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 142.28B |
| March 31, 2026 | 116.58B |
| December 31, 2025 | 112.48B |
| September 30, 2025 | 114.94B |
| June 30, 2025 | 100.92B |
| March 31, 2025 | 89.39B |
| December 31, 2024 | 78.71B |
| September 30, 2024 | 75.61B |
| June 30, 2024 | 71.87B |
| March 31, 2024 | 63.94B |
| December 31, 2023 | 64.01B |
| September 30, 2023 | 57.92B |
| June 30, 2023 | 54.81B |
| March 31, 2023 | 53.16B |
| December 31, 2022 | 49.49B |
| September 30, 2022 | 47.46B |
| June 30, 2022 | 47.06B |
| March 31, 2022 | 46.92B |
| December 31, 2021 | 48.81B |
| September 30, 2021 | 48.19B |
| June 30, 2021 | 47.81B |
| March 31, 2021 | 46.84B |
| December 31, 2020 | 46.63B |
| September 30, 2020 | 43.95B |
| June 30, 2020 | 41.97B |
| Date | Value |
|---|---|
| March 31, 2020 | 41.10B |
| December 31, 2019 | 39.29B |
| September 30, 2019 | 37.89B |
| June 30, 2019 | 38.67B |
| March 31, 2019 | 38.01B |
| December 31, 2018 | 43.91B |
| September 30, 2018 | 44.63B |
| June 30, 2018 | 42.36B |
| March 31, 2018 | 44.36B |
| December 31, 2017 | 44.98B |
| September 30, 2017 | 43.01B |
| June 30, 2017 | 40.95B |
| March 31, 2017 | 37.62B |
| December 31, 2016 | 38.81B |
| September 30, 2016 | 37.59B |
| June 30, 2016 | 36.48B |
| March 31, 2016 | 34.69B |
| December 31, 2015 | 35.57B |
| September 30, 2015 | 36.30B |
| June 30, 2015 | 36.04B |
| March 31, 2015 | 35.65B |
| December 31, 2014 | 37.18B |
| September 30, 2014 | 34.65B |
| June 30, 2014 | 35.02B |
| March 31, 2014 | 34.76B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| Merck & Co., Inc. | 129.80B |
| Pfizer Inc. | 201.13B |
| Bristol Myers Squibb Co. | 87.63B |
| Atai Beckley, Inc. | 264.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 108.40B |
| Shareholders Equity (Quarterly) | 33.88B |
| Debt to Equity Ratio | 1.621 |
| Current Ratio | 1.355 |
| Net Debt Paydown Yield | -0.29% |